Betty Dong, PharmD

Professor

Department of Clinical Pharmacy

[email protected]

Phone: +1 415 206-5794

Fax: +1 415 476-6632

533 Parnassus Avenue, Rm 585

UCSF Box 0622

San Francisco, CA 94143

United States

Links

UCSF Profiles

Joint appointments

Professor, Department of Family and Community Medicine, School of Medicine

Educational programs

PharmD Degree Program

External affiliations

Clinical Pharmacist Consultant, National HIV/AIDS Clinicians' Consultation Center (NCCC)

Consultant, Federal Bureau of Prisons

What I do

My primary area is the clinical care of patients with hepatitis C infection, HIV, and chronic illnesses, including high blood pressure, diabetes, thyroid issues, patients on blood thinners and those who have difficulty with medication side effects or medication adherence (taking their medications). At the National HIV/AIDS Consultation Center, I provide clinical consultations via telephone for the Federal Board of Prisons and for healthcare providers caring for HIV and HCV infected patients, including pregnant women and their newborns. My practice sites include the Family Health Center located at Zuckerberg San Francisco General Hospital and the UCSF Liver Transplant Clinic. I also teach in the Doctor of Pharmacy curriculum and the Family Medicine program and conduct research in the aforementioned areas.

Departmental research area

clinical research

My research expertise

HIV and HCV therapy, thyroid products

Clinical expertise

HIV/AIDS, hepatitis C infection, hypertension, anticoagulation, endocrinology, family practice, primary care

Degrees

PharmD, University of California, San Francisco, 1972

Biography

Betty Dong, PharmD, FCCP, FASHP, AAHIVP provides pharmacy care for patients with HIV and HCV infection, hypertension, thrombosis requiring anticoagulation, diabetes, thyroid, medication nonadherence, and other chronic illnesses. She provides patient education, and medication and side effect monitoring for persons seen at the Family Medicine Clinic at San Francisco General Hospital and at the UCSF Liver Transplant Clinic. She is a consultant for the Clinicians' Consultation Center on treatment and prevention of HIV, HBV, and HCV infection in adults, children, and during pregnancy. She has published, lectured, and conducted research in the aforementioned areas.

Research keywords

Telecommunications, hepatitis C, pharmacists, Community Pharmacy Services, HIV Infections

Licensure and certifications

Licentiate in Pharmacy, California, 1972

AAHIVP, 2009

1.	Elected Practitioner, National Association of Practitioners, 2012
2.	Distinguished Alumni, UCSF School of Pharmacy Alumni Association, 2010
3.	Clinical Practice Award, American College of Clinical Pharmacy, 2004
4.	Elected Fellow, American College of Clinical Pharmacy, 2004
5.	Elected Fellow, American Society of Health System Pharmacists, 2004
6.	Anniversary Year Alumnus, Commencement Ceremony Class 2002, UCSF School of Pharmacy, 2002
7.	Pharmacist of the Year, California Society of Health System Pharmacists, 2001-2002
8.	Residency Preceptor Award, UCSF Pharmacy Residents, Division of Clinical Pharmacy, 1990-1991
9.	Practitioner Fellow, California Society of Health System Pharmacists, 1990
10.	Outstanding Teaching Award - Family Practice Residency Program, SFGH; Department of Family and Commu, UCSF Department of FCM, 1988
11.	Long Froundation Award, UCSF School of Pharmacy, 1987
12.	NewHouse Award, UCSF, 1971-1972

Publications

Dong BJ, Lopez MI, Grant RM. Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States. Open Forum Infect Dis. 2019 Dec; 6(12):ofz497.

Lopez MI, Cocohoba J, Cohen SE, Trainor N, Levy MM, Dong BJ. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health. J Am Pharm Assoc (2003). 2019 Aug 09.

Dong BJ, Williams MR, Bingham JT, Tokumoto J, Allen JD. Outcome of challenging HIV case consultations provided via teleconference by the Clinician Consultation Center to the Federal Bureau of Prisons. J Am Pharm Assoc (2003). 2017 Jul - Aug; 57(4):516-519.

Dong BJ, Lopez M, Cocohoba J. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project. J Am Pharm Assoc (2003). 2017 Jul - Aug; 57(4):510-515.e2.

Goldschmidt RH, Chu C, Dong BJ. Initial Management of Patients with HIV Infection. Am Fam Physician. 2016 Nov 01; 94(9):708-716.

Trang TP, Dong BJ, Kojima N, Klausner JD. Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection. Expert Opin Drug Saf. 2016 Sep; 15(9):1287-94.

Mohammad RA, Bulloch MN, Chan J, Deming P, Love B, Smith L, Dong BJ. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2014 Dec; 34(12):1341-54.

Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85.

Medina MS, Plaza CM, Stowe CD, Robinson ET, DeLander G, Beck DE, Melchert RB, Supernaw RB, Roche VF, Gleason BL, Strong MN, Bain A, Meyer GE, Dong BJ, Rochon J, Johnston P. Center for the Advancement of Pharmacy Education 2013 educational outcomes. Am J Pharm Educ. 2013 Oct 14; 77(8):162.

Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41.

Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322.

Sherman EM, Cocohoba JM, Neff SE, Dong BJ. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Ann Pharmacother. 2011 Dec; 45(12):1499-505.

Cocohoba J, Dong BJ. Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008 Oct; 30(10):1747-65.

Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6.

Dong BJ, Cocohoba JM. Tipranavir: a protease inhibitor for HIV salvage therapy. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1311-21.

Clay PG, Dong BJ, Sorensen SJ, Tseng A, Romanelli F, Antoniou T. Advances in human immunodeficiency virus therapeutics. Ann Pharmacother. 2006 Apr; 40(4):704-9.

Dong BJ. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther. 2005 Nov; 27(11):1725-51.

Lim ML, Dong BJ, Hart SL. Outcomes of dual-protease inhibitor salvage therapy in human immunodeficiency virus-infected patients referred to a telephone consultation service. Pharmacotherapy. 2003 Sep; 23(9):1100-4.

Goldschrnidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions--2002: antiretroviral therapy. J Am Board Fam Pract. 2002 Jul-Aug; 15(4):319-31.